# Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

> **NCT00054041** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 84 (actual)

## Conditions studied

- Cervical Cancer
- Cervical Intraepithelial Neoplasia Grade 3
- Human Papilloma Virus Infection

## Interventions

- **BIOLOGICAL:** HspE7
- **PROCEDURE:** therapeutic conventional surgery
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00054041
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054041, "Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00054041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*